About Matthias Therapeutics
Matthias Therapeutics is a private company based in Basking Ridge, New Jersey, incorporated in 2023 in Delaware. It has reported $150,000 raised in two offerings on Form D since January 2026. Its chief executive is Matthew Redling.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 14, 2026 | Jun 1, 2026 | $50,000of $500K target | 1 | $50,000 | Debt, OptionsRule 506(b) | Form D ↗ |
| Nov 24, 2025 | Jan 7, 2026 | $100,000of $500K target | 2 | $50,000 | Debt, OptionsRule 506(b) | Form D ↗ |
| Total, two offerings | $150,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Matthias Therapeutics's Form D filed Jun 1, 2026.
MR
Matthew Redling
Chief Executive Officer
Sources
- SECMatthias Therapeutics, LLC filing history
- CompanyPrivacy Policy
- CompanyAbout